These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3339265)

  • 1. Rapid and sensitive analysis of 8-methoxypsoralen in plasma.
    Gasparro FP; Battista J; Song J; Edelson RL
    J Invest Dermatol; 1988 Feb; 90(2):234-6. PubMed ID: 3339265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma levels of 8-methoxypsoralen determined by high-pressure liquid chromatography in psoriatic patients ingesting drug from two manufacturers.
    Ljunggren B; Carter DM; Albert J; Reid T
    J Invest Dermatol; 1980 Jan; 74(1):59-62. PubMed ID: 7351495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation and routine application of the novel restricted-access precolumn packing material Alkyl-Diol Silica: coupled-column high-performance liquid chromatographic analysis of the photoreactive drug 8-methoxypsoralen in plasma.
    Vielhauer S; Rudolphi A; Boos KS; Seidel D
    J Chromatogr B Biomed Appl; 1995 Apr; 666(2):315-22. PubMed ID: 7633608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring of 8-methoxypsoralen during extracorporeal photochemotherapy: evidence for a "first-dose" effect.
    Jacolot A; Tod M; Heudes AM; Petitjean O; Laroche L
    Ther Drug Monit; 1996 Jun; 18(3):234-9. PubMed ID: 8738761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Determination of 8-methoxypsoralen in mouse plasma by high performance liquid chromatography and its application to pharmacokinetic study].
    Wu TW; Cui R; Zhang BX
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Oct; 50(5):792-796. PubMed ID: 30337737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of methoxsalen in plasma by reversed-phase high-performance liquid chromatography.
    Monbaliu JG; Rosseel MT; Bogaert MG
    J Pharm Sci; 1981 Aug; 70(8):965-6. PubMed ID: 7310677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic and clinical comparison of two 8-methoxypsoralen brands.
    Andersen KE; Menne T; Gammeltoft M; Hjorth N; Larsen E; Solgaard P
    Arch Dermatol Res; 1980; 268(1):23-9. PubMed ID: 7416795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma levels of 8-methoxypsoralen in psoriatic patients receiving topical 8-methoxypsoralen.
    Neild VS; Scott LV
    Br J Dermatol; 1982 Feb; 106(2):199-203. PubMed ID: 7059510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 8-Methoxypsoralen levels in blood of vitiligo patients and in skin, ophthalmic fluids, and ocular tissues of the guinea pig.
    Chakrabarti SG; Halder RM; Johnson BA; Minus HR; Pradhan TK; Kenney JA
    J Invest Dermatol; 1986 Aug; 87(2):276-9. PubMed ID: 3734475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levels of 8-methoxypsoralen 2 hours after oral administration.
    Steiner I; Prey T; Gschnait F; Washüttl J; Greiter F
    Acta Derm Venereol; 1978; 58(2):185-8. PubMed ID: 76402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-response relations in phototoxicity due to 8-methoxypsoralen and UV-A in man.
    Ljunggren B; Bjellerup M; Carter DM
    J Invest Dermatol; 1981 Feb; 76(2):73-5. PubMed ID: 7462679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics of 8-methoxypsoralen and 5-methoxypsoralen distribution in guinea pig serum, epidermis and ocular lens.
    Wamer W; Giles A; Kornhauser A
    Photodermatol; 1987 Oct; 4(5):236-9. PubMed ID: 3697346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new liquid formulation of 8-methoxypsoralen: bioactivity and effect of diet.
    Levins PC; Gange RW; Momtaz-T K; Parrish JA; Fitzpatrick TB
    J Invest Dermatol; 1984 Feb; 82(2):185-7. PubMed ID: 6693780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Standardizing 8-methoxypsoralen plasma profiles by using an emulsion form.
    Van Boven M; Roelandts R; Adriaens P; Daenens P; Degreef H; Kinget R
    J Am Acad Dermatol; 1985 May; 12(5 Pt 1):822-7. PubMed ID: 4008686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma levels of 8-methoxypsoralen and phototoxicity studies during PUVA treatment of psoriasis with meladinin tablets.
    Thune P
    Acta Derm Venereol; 1978; 58(2):149-51. PubMed ID: 76395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photochemotherapy of psoriasis with relevance to 8-methoxypsoralen plasma level and low intensity irradiation.
    Thune P; Volden G
    Acta Derm Venereol; 1977; 57(4):351-5. PubMed ID: 70930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between 8-methoxypsoralen skin and blood levels.
    Roelandts R; Van Boven M; Adriaens P; De Schryver F; Degreef H
    J Invest Dermatol; 1983 Oct; 81(4):331-3. PubMed ID: 6619562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of 5-methoxypsoralen in human serum.
    Wang LH; Tso M
    J Pharm Biomed Anal; 2002 Oct; 30(3):593-600. PubMed ID: 12367684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitation of plasma levels of 8-methoxypsoralen by competitive enzyme-linked immunosorbent assay.
    Yin BY; Gasparro FP; Bevilacqua PM; Santella RM
    J Invest Dermatol; 1991 Dec; 97(6):1001-4. PubMed ID: 1748809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of 8-methoxypsoralen by high-performance liquid chromatography.
    Ketchum CH; Robinson CA; Huang ST
    Clin Chem; 1990 Nov; 36(11):1956-7. PubMed ID: 2242576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.